Authors:
Namer, M
Soler-Michel, P
Turpin, F
Chinet-Charrot, P
de Gislain, C
Pouillart, P
Delozier, T
Luporsi, E
Etienne, PL
Schraub, S
Eymard, JC
Serin, D
Ganem, G
Calais, G
Maillart, P
Colin, P
Trillet-Lenoir, V
Prevost, G
Tigaud, D
Clavere, P
Marti, P
Romieu, C
Wendling, JL
Citation: M. Namer et al., Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer, EUR J CANC, 37(9), 2001, pp. 1132-1140
Authors:
Bail, P
Bizel, P
Bonnard, J
Compagnon, C
Dosquet, P
Dubois, S
Dupuis, G
Fabre, H
Glorion, B
Lienhart, A
Nicolas, F
Noel, AP
Pazart, L
Pinell, P
Pellerin, D
Sargos, P
Serin, D
Thouvenin, D
Thurin, JM
Chapiro, O
Cordonnier, D
Darcourt, G
Delcey, M
Esper, C
Freile, R
Grall, JC
Haxaire, C
Herrmann, P
Hirsch, E
Hirszowski, F
Jacquet, JP
Lascoumes, P
Lassner, E
Leport, C
Lieutaud, P
Locquet, C
Mairesse, JP
Mayaud, C
May-Levin, F
Michel, C
Mopin, J
Moser, S
Papa, M
Perrier, JM
Pochet, P
Richard, D
Sautron, JB
Torre, E
Tricoire, MJ
Vasseur, E
Wagner-Ballon, J
Citation: P. Bail et al., Patient information: guidelines for physicians, J MAL VASC, 26(2), 2001, pp. 101-104
Authors:
Cutuli, B
Janvier, M
de la Rochefordiere, A
Julien, JP
Isambert, N
Alzieu, C
Kerbrat, P
de Lafontan, B
van Lemmens, L
Cure, H
Ganem, G
Baume, D
Le Mevel, A
Lorthoraly, A
de Gislain, C
Marchal, C
Chevelle, C
Lauche, H
Serin, D
Citation: B. Cutuli et al., Leukemias and preleukemic states developing after treatment of breast cancer, PRESSE MED, 29(3), 2000, pp. 135-138
Authors:
Veronesi, U
von Kleist, S
Redmond, K
Costa, A
Delvaux, N
Freilich, G
Glaus, A
Hudson, T
McVie, JG
Macnamara, C
Meunier, F
Pecorelli, S
Serin, D
Citation: U. Veronesi et al., Caring About Women and Cancer (CAWAC): A European survey of the perspectives and experiences of women with female cancers, EUR J CANC, 35(12), 1999, pp. 1667-1675